UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 349

Sortiert nach

Bone Regulators and Osteoporosis Therapy

1st Edition 2020, 2020

Link zum Volltext

Verfügbarkeit prüfen

Editorial: Chemokines and Bone

Frontiers in endocrinology (Lausanne), 2018-07, Vol.9, p.386-386

2018

Link zum Volltext

Verfügbarkeit prüfen

How Vitamin D Works on Bone

Endocrinology and metabolism clinics of North America, 2012-09, Vol.41 (3), p.557-569

2012

Link zum Volltext

Verfügbarkeit prüfen

The Calcineurin/Nuclear Factor of Activated T Cells Signaling Pathway Regulates Osteoclastogenesis in RAW264.7 Cells

The Journal of biological chemistry, 2004-04, Vol.279 (14), p.13984-13992

2004

Link zum Volltext

Verfügbarkeit prüfen

Antiresorptive agents and osteoclast apoptosis

Journal of cellular biochemistry, 2007-08, Vol.101 (5), p.1087-1096

Stern, Paula H.

2007

Link zum Volltext

Verfügbarkeit prüfen

Dentin Phosphoprotein Binds Annexin 2 and Is Involved in Calcium Transport in Rat Kidney Ureteric Bud Cells

The Journal of biological chemistry, 2013-05, Vol.288 (18), p.13036-13045

2013

Link zum Volltext

Verfügbarkeit prüfen

In Memoriam: William A. Peck, MD

Journal of bone and mineral research, 2023-06, Vol.38 (6), p.809-811

2023

Link zum Volltext

Verfügbarkeit prüfen

Direct inhibitory and indirect stimulatory effects of RAGE ligand S100 on sRANKL-induced osteoclastogenesis

Journal of cellular biochemistry, 2009-08, Vol.107 (5), p.917-925

2009

Link zum Volltext

Verfügbarkeit prüfen

The small GTPase RhoA is crucial for MC3T3-E1 osteoblastic cell survival

Journal of cellular biochemistry, 2009-04, Vol.106 (5), p.896-902

2009

Link zum Volltext

Verfügbarkeit prüfen

Reveromycin A, an Agent for Osteoporosis, Inhibits Bone Resorption by Inducing Apoptosis Specifically in Osteoclasts

Proceedings of the National Academy of Sciences - PNAS, 2006-03, Vol.103 (12), p.4729-4734

2006

Link zum Volltext

Verfügbarkeit prüfen

Antitumor Agent Cabozantinib Decreases RANKL Expression in Osteoblastic Cells and Inhibits Osteoclastogenesis and PTHrP-Stimulated Bone Resorption

Journal of cellular biochemistry, 2014-11, Vol.115 (11), p.2033-2038

2014

Link zum Volltext

Verfügbarkeit prüfen

Sex-specific effects of estrogen and androgen on gene expression in human monocyte-derived osteoclasts

Journal of cellular biochemistry, 2011-12, Vol.112 (12), p.3714-3721

2011

Link zum Volltext

Verfügbarkeit prüfen

Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) project

Journal of bone and joint surgery. American volume, 2013-02, Vol.95 (4), p.297

2013

Link zum Volltext

Verfügbarkeit prüfen

Alan Poland, MS, MD: 1940–2020 Poisons as Probes of Biological Function

Chemical research in toxicology, 2021-01, Vol.34 (1), p.1-4

2021

Link zum Volltext

Verfügbarkeit prüfen

Osteoclastogenic activity and RANKL expression are inhibited in osteoblastic cells expressing constitutively active Gα12 or constitutively active RhoA

Journal of cellular biochemistry, 2010-12, Vol.111 (6), p.1531-1536

2010

Link zum Volltext

Verfügbarkeit prüfen

Regulation of Breast Cancer-induced Bone Lesions by β-Catenin Protein Signaling

The Journal of biological chemistry, 2011-12, Vol.286 (49), p.42575-42584

2011

Link zum Volltext

Verfügbarkeit prüfen

Lawrence Gideon Raisz Nov 13, 1925–August 25, 2010

Bone (New York, N.Y.), 2010-11, Vol.47 (5), p.846-847

Stern, Paula H

2010

Link zum Volltext

Verfügbarkeit prüfen

Systemic delivery of oncolytic adenoviruses targeting transforming growth factor-β inhibits established bone metastasis in a prostate cancer mouse model

Human gene therapy, 2012-08, Vol.23 (8), p.871

2012

Link zum Volltext

Verfügbarkeit prüfen

Osteoclastogenic activity and RANKL expression are inhibited in osteoblastic cells expressing constitutively active Gα(12) or constitutively active RhoA

Journal of cellular biochemistry, 2010-12, Vol.111 (6), p.1531-1536

2010

Link zum Volltext

Verfügbarkeit prüfen

Effects of a selective cyclooxygenase-2 inhibitor, celecoxib, on bone resorption and osteoclastogenesis in vitro

Biochemical pharmacology, 2002-02, Vol.63 (3), p.523-532

2002

Link zum Volltext

Verfügbarkeit prüfen

The Calcineurin-NFAT Pathway and Bone: Intriguing New Findings

Molecular interventions, 2006-08, Vol.6 (4), p.193-196

Stern, Paula H

2006

Link zum Volltext

Verfügbarkeit prüfen

Drugs Causing Bone Loss

Bone Regulators and Osteoporosis Therapy, 2020, Vol.262, p.475-497

2020

Link zum Volltext

Verfügbarkeit prüfen

Rho GTPase signaling and PTH 3–34, but not PTH 1–34, maintain the actin cytoskeleton and antagonize bisphosphonate effects in mouse osteoblastic MC3T3-E1 cells

Bone (New York, N.Y.), 2009-07, Vol.45 (1), p.52-60

2009

Link zum Volltext

Verfügbarkeit prüfen

PTH and PTHrP Actions on Bone

Bone Regulators and Osteoporosis Therapy, 2020, Vol.262, p.27-45

2020

Link zum Volltext

Verfügbarkeit prüfen

Thyroid Hormones, Glucocorticoids, Insulin, and Bone

Bone Regulators and Osteoporosis Therapy, 2020, Vol.262, p.93-120

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 349

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(335)
Mit Volltextzugriff
(288)

Publikationsform

Sprache

Englisch
(347)
Japanisch
(52)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(236)
Life Sciences & Biomedicine
(191)
Humans
(167)
Female
(120)
Male
(115)
Aged
(106)
Animals
(89)
Alzheimer's Disease
(78)
Neurosciences & Neurology
(67)
Biological And Medical Sciences
(66)
Aged, 80 And Over
(61)
Neuroimaging
(61)
Endocrinology & Metabolism
(52)
Magnetic Resonance Imaging
(51)
Middle Aged
(51)
Medical Imaging
(47)
Neurosciences
(46)
Rats
(45)
Multidisciplinary Sciences
(42)
Science & Technology - Other Topics
(42)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Science
(28)
Journal Of Bone And Mineral Research
(25)
Neurology
(18)
Scientific Reports
(17)
Journal Of Cellular Biochemistry
(14)
Brain Imaging And Behavior
(13)
Endocrinology
(13)
Nature Communications
(13)
Calcified Tissue International
(10)
Neuroimage
(9)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Bone Regulators and Osteoporosis Therapy

Editorial: Chemokines and Bone

How Vitamin D Works on Bone

The Calcineurin/Nuclear Factor of Activated T Cells Signaling Pathway Regulates Osteoclastogenesis in RAW264.7 Cells

Antiresorptive agents and osteoclast apoptosis

Dentin Phosphoprotein Binds Annexin 2 and Is Involved in Calcium Transport in Rat Kidney Ureteric Bud Cells

In Memoriam: William A. Peck, MD

Direct inhibitory and indirect stimulatory effects of RAGE ligand S100 on sRANKL-induced osteoclastogenesis

The small GTPase RhoA is crucial for MC3T3-E1 osteoblastic cell survival

Reveromycin A, an Agent for Osteoporosis, Inhibits Bone Resorption by Inducing Apoptosis Specifically in Osteoclasts

Antitumor Agent Cabozantinib Decreases RANKL Expression in Osteoblastic Cells and Inhibits Osteoclastogenesis and PTHrP-Stimulated Bone Resorption

Sex-specific effects of estrogen and androgen on gene expression in human monocyte-derived osteoclasts

Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) project

Alan Poland, MS, MD: 1940–2020 Poisons as Probes of Biological Function

Osteoclastogenic activity and RANKL expression are inhibited in osteoblastic cells expressing constitutively active Gα12 or constitutively active RhoA

Regulation of Breast Cancer-induced Bone Lesions by β-Catenin Protein Signaling

Lawrence Gideon Raisz Nov 13, 1925–August 25, 2010

Systemic delivery of oncolytic adenoviruses targeting transforming growth factor-β inhibits established bone metastasis in a prostate cancer mouse model

Osteoclastogenic activity and RANKL expression are inhibited in osteoblastic cells expressing constitutively active Gα(12) or constitutively active RhoA

Effects of a selective cyclooxygenase-2 inhibitor, celecoxib, on bone resorption and osteoclastogenesis in vitro

The Calcineurin-NFAT Pathway and Bone: Intriguing New Findings

Drugs Causing Bone Loss

Rho GTPase signaling and PTH 3–34, but not PTH 1–34, maintain the actin cytoskeleton and antagonize bisphosphonate effects in mouse osteoblastic MC3T3-E1 cells

PTH and PTHrP Actions on Bone

Thyroid Hormones, Glucocorticoids, Insulin, and Bone

Suchergebnisse filtern